Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Clene ( (CLNN) ) has issued an announcement.
On April 28, 2025, Clene Inc. entered into an equity distribution agreement with Canaccord Genuity LLC to offer and sell shares of its common stock, aiming to raise up to $25,000,000. By September 5, 2025, the company had already sold shares worth approximately $3,706,213 and filed a prospectus supplement for an additional $6,280,000 of shares, reflecting its ongoing efforts to bolster financial resources.
The most recent analyst rating on (CLNN) stock is a Buy with a $31.00 price target. To see the full list of analyst forecasts on Clene stock, see the CLNN Stock Forecast page.
Spark’s Take on CLNN Stock
According to Spark, TipRanks’ AI Analyst, CLNN is a Neutral.
Clene’s overall stock score is primarily influenced by its financial instability, which poses significant risks. However, strong technical indicators and positive corporate events, such as regulatory progress and Nasdaq compliance, provide some optimism. The valuation remains a concern due to ongoing losses.
To see Spark’s full report on CLNN stock, click here.
More about Clene
Average Trading Volume: 79,373
Technical Sentiment Signal: Buy
Current Market Cap: $59.44M
See more data about CLNN stock on TipRanks’ Stock Analysis page.